Key Dates

Related Announcements

• September 08, 2022 - Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed). See NOFO PAR-22-242.
• September 08, 2022 - Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional). See NOFO PAR-22-243.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

Background

Due to the growing cost of individual grant applications and reduced use of the modular budget format, NINDS is faced with a challenging budgetary landscape. To maintain support for as many investigators as possible in this current environment requires careful management of research projects with large budgets.  Effective immediately, NINDS will no longer be supporting grant applications requesting $500,000 or more in direct costs in any year (excluding consortium F&A) submitted in response to PAR-22-242 and PAR-22-243 Notices of Funding Opportunities (NOFOs) and their reissues.

Policy

Applications requesting $500,000 or more in direct costs in any year (excluding consortium F&A) will not be supported.  Please see Section IV.7 of the NOFO under “Requests of $500,000 or more for direct costs in any year.” NINDS will not approve applications proposing a budget of greater than $500k in any given year. This policy applies to all competing applications submitted to PAR-22-242 and PAR-22-243 NOFOs without exception.

This policy is effective October 24, 2024 and applies to applications under consideration at the National Advisory Neurological Disorders and Stroke Council (NANDSC) May 2025 and subsequent meetings.

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:

NINDS $500K Policy
National Institute of Neurological Disorders and Stroke (NINDS)
Email: [email protected]

Scientific/Research Contact(s)

Doe Kumsa, Ph.D. 
National Institute of Neurological Disorders and Stroke (NINDS)
Email: [email protected]